Preemptive therapy for cytomegalovirus with oral ganciclovir after liver transplantation
- PMID: 12131704
- DOI: 10.1097/00007890-200206270-00028
Preemptive therapy for cytomegalovirus with oral ganciclovir after liver transplantation
Comment on
-
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation.Transplantation. 2001 Sep 15;72(5):881-5. doi: 10.1097/00007890-200109150-00024. Transplantation. 2001. PMID: 11571454 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
